Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells

S. Skolekova, M. Matuskova, M. Bohac, L. Toro, E. Durinikova, S. Tyciakova, L. Demkova, J. Gursky, L. Kucerova,

. 2016 ; 14 (-) : 4. [pub] 20160112

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17000658

BACKGROUND: Cells of the tumor microenvironment are recognized as important determinants of the tumor biology. The adjacent non-malignant cells can regulate drug responses of the cancer cells by secreted paracrine factors and direct interactions with tumor cells. RESULTS: Human mesenchymal stromal cells (MSC) actively contribute to tumor microenvironment. Here we focused on their response to chemotherapy as during the treatment these cells become affected. We have shown that the secretory phenotype and behavior of mesenchymal stromal cells influenced by cisplatin differs from the naïve MSC. MSC were more resistant to the concentrations of cisplatin, which was cytotoxic for tumor cells. They did not undergo apoptosis, but a part of MSC population underwent senescence. However, MSC pretreatment with cisplatin led to changes in phosphorylation profiles of many kinases and also increased secretion of IL-6 and IL-8 cytokines. These changes in cytokine and phosphorylation profile of MSC led to increased chemoresistance and stemness of breast cancer cells. CONCLUSION: Taken together here we suggest that the exposure of the chemoresistant cells in the tumor microenvironment leads to substantial alterations and might lead to promotion of acquired microenvironment-mediated chemoresistance and stemness.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17000658
003      
CZ-PrNML
005      
20170116094142.0
007      
ta
008      
170103s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12964-016-0127-0 $2 doi
024    7_
$a 10.1186/s12964-016-0127-0 $2 doi
035    __
$a (PubMed)26759169
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Skolekova, Svetlana $u Laboratory of Molecular Oncology, Cancer Research Institute, Slovak Academy of Sciences, Vlarska 7, 833 91, Bratislava, Slovakia. svetlana.skolekova@savba.sk.
245    10
$a Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells / $c S. Skolekova, M. Matuskova, M. Bohac, L. Toro, E. Durinikova, S. Tyciakova, L. Demkova, J. Gursky, L. Kucerova,
520    9_
$a BACKGROUND: Cells of the tumor microenvironment are recognized as important determinants of the tumor biology. The adjacent non-malignant cells can regulate drug responses of the cancer cells by secreted paracrine factors and direct interactions with tumor cells. RESULTS: Human mesenchymal stromal cells (MSC) actively contribute to tumor microenvironment. Here we focused on their response to chemotherapy as during the treatment these cells become affected. We have shown that the secretory phenotype and behavior of mesenchymal stromal cells influenced by cisplatin differs from the naïve MSC. MSC were more resistant to the concentrations of cisplatin, which was cytotoxic for tumor cells. They did not undergo apoptosis, but a part of MSC population underwent senescence. However, MSC pretreatment with cisplatin led to changes in phosphorylation profiles of many kinases and also increased secretion of IL-6 and IL-8 cytokines. These changes in cytokine and phosphorylation profile of MSC led to increased chemoresistance and stemness of breast cancer cells. CONCLUSION: Taken together here we suggest that the exposure of the chemoresistant cells in the tumor microenvironment leads to substantial alterations and might lead to promotion of acquired microenvironment-mediated chemoresistance and stemness.
650    _2
$a protinádorové látky $x farmakologie $7 D000970
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a prsy $x účinky léků $x imunologie $7 D001940
650    _2
$a nádory prsu $x farmakoterapie $x imunologie $7 D001943
650    _2
$a stárnutí buněk $x účinky léků $7 D016922
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a cisplatina $x farmakologie $7 D002945
650    _2
$a chemorezistence $7 D019008
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a interleukin-6 $x imunologie $7 D015850
650    _2
$a interleukin-8 $x imunologie $7 D016209
650    _2
$a mezenchymální kmenové buňky $x cytologie $x účinky léků $x imunologie $7 D059630
650    _2
$a nádorové mikroprostředí $x účinky léků $7 D059016
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Matuskova, Miroslava $u Laboratory of Molecular Oncology, Cancer Research Institute, Slovak Academy of Sciences, Vlarska 7, 833 91, Bratislava, Slovakia. miroslava.matuskova@savba.sk.
700    1_
$a Bohac, Martin $u Department of Plastic, Aesthetic and Reconstructive Surgery, University Hospital, Bratislava, Slovakia. bohac.md@gmail.com.
700    1_
$a Toro, Lenka $u Laboratory of Molecular Oncology, Cancer Research Institute, Slovak Academy of Sciences, Vlarska 7, 833 91, Bratislava, Slovakia. exonbara@savba.sk.
700    1_
$a Durinikova, Erika
700    1_
$a Tyciakova, Silvia
700    1_
$a Demkova, Lucia $u Laboratory of Molecular Oncology, Cancer Research Institute, Slovak Academy of Sciences, Vlarska 7, 833 91, Bratislava, Slovakia. lucia.demkova@savba.sk.
700    1_
$a Gursky, Jan $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 5, Olomouc, Czech Republic. jan.gursky@upol.cz.
700    1_
$a Kucerova, Lucia $u Laboratory of Molecular Oncology, Cancer Research Institute, Slovak Academy of Sciences, Vlarska 7, 833 91, Bratislava, Slovakia. lucia.kucerova@savba.sk.
773    0_
$w MED00008216 $t Cell communication and signaling CCS $x 1478-811X $g Roč. 14, č. - (2016), s. 4
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26759169 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170103 $b ABA008
991    __
$a 20170116094247 $b ABA008
999    __
$a ok $b bmc $g 1179798 $s 961225
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 14 $c - $d 4 $e 20160112 $i 1478-811X $m Cell communication and signaling $n Cell Commun Signal $x MED00008216
LZP    __
$a Pubmed-20170103

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...